Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof inventions 10/09

20090247731 - Boronic ester and acid compounds, synthesis and uses: Disclosed herein is a method for reducing the rate of degradation of proteins in an animal, comprising contacting cells of the animal with certain boronic ester and acid compounds. Also disclosed herein are novel boronic ester and acid compounds, their synthesis and uses.... Agent: Millennium Pharmaceuticals, Inc.

20090247732 - Synthesis of glycopeptides with superior pharmacokinetic properties: The present invention relates to novel glycopeptides having improved pharmacokinetic properties, improved stability, methods of preparing said novel glycopeptides, and methods to use said novel glycopeptides.... Agent: Catalyst Law Group, Apc

20090247733 - Novel bone mineralization proteins, dna, vectors, expression systems: The present invention is directed to isolated nucleic acid molecules that encode LIM mineralization protein, or LMP. The invention further provides vectors comprising nucleotide sequences that encode LMP, as well as host cells comprising those vectors. Moreover, the present invention relates to methods of inducing bone formation by transfecting osteogenic... Agent: Medtronic Attn: Noreen Johnson - Ip Legal Department

20090247734 - Chemically derivatized cd4 and uses thereof: This invention provides two soluble polypeptides which comprise a portion of CD4 comprising all HIV gp120-binding epitopes present on intact CD4, wherein the polypeptide has a cysteine substitution at a residue which, in intact CD4, interfaces with HIV gp120. This invention also provides a method for making a derivatized soluble... Agent: Cooper & Dunham, LLP

20090247735 - Enhanced capacity and purification of protein by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers: This invention relates to the use of mixed mode chromatography for purification of a protein from a mixture containing other materials, including fragmented or aggregated antibodies, host cell proteins, DNA, endotoxin, and/or virus. This invention further relates to the integration of such a method into a multi-step procedure with other... Agent: Townsend And Townsend And Crew, LLP